The role of circulating free DNA in the management of NSCLC

作者: Riziero Esposito Abate , Raffaella Pasquale , Francesca Fenizia , Anna Maria Rachiglio , Cristin Roma

DOI: 10.1080/14737140.2019.1548938

关键词:

摘要: Introduction: Circulating cell-free DNA (cfDNA) testing has emerged as an alternative to tumor tissue analyses for the management of metastatic non-small-cell lung cancer (NSCLC) patients. Analysis...

参考文章(85)
Richard B. Lanman, Stefanie A. Mortimer, Oliver A. Zill, Dragan Sebisanovic, Rene Lopez, Sibel Blau, Eric A. Collisson, Stephen G. Divers, Dave S. B. Hoon, E. Scott Kopetz, Jeeyun Lee, Petros G. Nikolinakos, Arthur M. Baca, Bahram G. Kermani, Helmy Eltoukhy, AmirAli Talasaz, Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA PLOS ONE. ,vol. 10, pp. e0140712- ,(2015) , 10.1371/JOURNAL.PONE.0140712
Francesca Fenizia, Antonella De Luca, Raffaella Pasquale, Alessandra Sacco, Laura Forgione, Matilde Lambiase, Alessia Iannaccone, Nicoletta Chicchinelli, Renato Franco, Antonio Rossi, Alessandro Morabito, Gaetano Rocco, Maria Carmela Piccirillo, Nicola Normanno, EGFR mutations in lung cancer: from tissue testing to liquid biopsy. Future Oncology. ,vol. 11, pp. 1611- 1623 ,(2015) , 10.2217/FON.15.23
Raffaella Pasquale, Francesca Fenizia, Riziero Esposito Abate, Alessandra Sacco, Claudia Esposito, Laura Forgione, Anna Maria Rachiglio, Simona Bevilacqua, Agnese Montanino, Renato Franco, Gaetano Rocco, Gerardo Botti, Marc G Denis, Alessandro Morabito, Antonella De Luca, Nicola Normanno, Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients Pharmacogenomics. ,vol. 16, pp. 1135- 1148 ,(2015) , 10.2217/PGS.15.45
Aaron M Newman, Scott V Bratman, Jacqueline To, Jacob F Wynne, Neville C W Eclov, Leslie A Modlin, Chih Long Liu, Joel W Neal, Heather A Wakelee, Robert E Merritt, Joseph B Shrager, Billy W Loo, Ash A Alizadeh, Maximilian Diehn, An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage Nature Medicine. ,vol. 20, pp. 548- 554 ,(2014) , 10.1038/NM.3519
Niki Karachaliou, Clara Mayo-de las Casas, Cristina Queralt, Itziar de Aguirre, Boris Melloni, Felipe Cardenal, Ramon Garcia-Gomez, Bartomeu Massuti, José Miguel Sánchez, Ruth Porta, Santiago Ponce-Aix, Teresa Moran, Enric Carcereny, Enriqueta Felip, Isabel Bover, Amelia Insa, Noemí Reguart, Dolores Isla, Alain Vergnenegre, Filippo de Marinis, Radj Gervais, Romain Corre, Luis Paz-Ares, Daniela Morales-Espinosa, Santiago Viteri, Ana Drozdowskyj, Núria Jordana-Ariza, Jose Luis Ramirez-Serrano, Miguel Angel Molina-Vila, Rafael Rosell, Spanish Lung Cancer Group, Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial. JAMA Oncology. ,vol. 1, pp. 149- 157 ,(2015) , 10.1001/JAMAONCOL.2014.257
Maria E. Arcila, Geoffrey R. Oxnard, Khedoudja Nafa, Gregory J. Riely, Stephen B. Solomon, Maureen F. Zakowski, Mark G. Kris, William Pao, Vincent A. Miller, Marc Ladanyi, Rebiopsy of Lung Cancer Patients with Acquired Resistance to EGFR Inhibitors and Enhanced Detection of the T790M Mutation Using a Locked Nucleic Acid-Based Assay Clinical Cancer Research. ,vol. 17, pp. 1169- 1180 ,(2011) , 10.1158/1078-0432.CCR-10-2277
Luis A. Diaz, Alberto Bardelli, Liquid Biopsies: Genotyping Circulating Tumor DNA Journal of Clinical Oncology. ,vol. 32, pp. 579- 586 ,(2014) , 10.1200/JCO.2012.45.2011
Florent Mouliere, Nitzan Rosenfeld, Circulating tumor-derived DNA is shorter than somatic DNA in plasma Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 3178- 3179 ,(2015) , 10.1073/PNAS.1501321112